Ferring Pharmaceuticals A/S is a Danish A/S based in Kastrup, operating in the Research and experimental development on natural sciences and engineering sector. Incorporated in 1992, the company has 526 employees and reported revenue of DKK 1.7bn in its latest annual filing.
Solidity ratio Equity ÷ Total assets × 100 Around the average of companies in the same industry
2021 2025
Liquidity ratio Current assets ÷ Short-term debt Among the 40% lowest rated companies in the industry
2021 2025
Return on assets (ROA) Net profit ÷ Total assets × 100 Around the average of companies in the same industry
2021 2025
EBITDA — year on year DKK millions 188M 141M 94M 47M 0M 2021: 54M 54M 2021 2022: 98M (+81% vs 2021) 98M +81% 2022 2023: 118M (+20% vs 2022) 118M +20% 2023 2024: 133M (+13% vs 2023) 133M +13% 2024 2025: 151M (+14% vs 2024) 151M +14% 2025
Key figures Annual report 2025 Revenue 1.7B DKK +2% EBITDA 0.2B DKK +13% Net profit 0B DKK -36% Total assets 0.7B DKK +21% Equity 0.3B DKK +18% Employees 526 —
Legal name
FERRING PHARMACEUTICALS A/S
Founded
1 August 1992 · 34 years
Financial year
January – December
Signatory rights
Selskabet tegnes af to bestyrelsesmedlemmer i forening eller af et bestyrelsesmedlem i forening med en direktør eller af to direktører i forening
Company purpose
Selskabets formål er forskning og udvikling af farmaceutiske produkter for selskaber i Ferring koncernen.
(no translation available)
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.comExplore Companies in Research and experimental development on natural sciences and engineering Companies in Tårnby All Denmark companiesFinancial development In its most recent annual report (2025), Ferring Pharmaceuticals A/S reported revenue of DKK 1.7bn, an increase of 2% on the year before. The figures on this page draw on 5 annual filings covering 2021 to 2025. The bottom line showed a net profit of DKK 49.0m, and the EBITDA margin stood at 8.7%.
At the end of 2025, equity financed 47% of the balance sheet, and current assets covered short-term debt 1.4 times. Ferring Pharmaceuticals A/S is one of 2 companies registered under Research and experimental development on natural sciences and engineering in Denmark.
Frequently asked questions What is the CVR number of Ferring Pharmaceuticals A/S? Ferring Pharmaceuticals A/S is registered with CVR / Virk under CVR 16313440.
What is the revenue of Ferring Pharmaceuticals A/S? Ferring Pharmaceuticals A/S reported revenue of DKK 1.7bn in 2025.
How many employees does Ferring Pharmaceuticals A/S have? Ferring Pharmaceuticals A/S employs 526 people as of the latest annual report.
Who is the CEO of Ferring Pharmaceuticals A/S? Jan Peutzfeldt is the CEO of Ferring Pharmaceuticals A/S, in role since 2024.
Who is the chairman of Ferring Pharmaceuticals A/S? Marianne Kock chairs the board of Ferring Pharmaceuticals A/S, in role since 2024.
Where is Ferring Pharmaceuticals A/S headquartered? Ferring Pharmaceuticals A/S's registered address is Amager Strandvej 405.
More on Ferring Pharmaceuticals A/S